Viewing StudyNCT02683746



Ignite Creation Date: 2024-05-06 @ 8:09 AM
Last Modification Date: 2024-10-26 @ 11:57 AM
Study NCT ID: NCT02683746
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2016-01-28

Brief Title: Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
Pharmacodynamics View
Safety View
Albiglutide View
Tolerability View
Type 2 Diabetes Mellitus View
Efficacy View